An efficient method oftransgene modulation in fertilized eggs has been developed that uses 
high expression of a potentially lethal transgene whose full activity is difficult to explore in a conventional transgenic system because of the risk of selecting for transgenic lines carrying only poorly expressed transgenes.
Development of the technology for gene transfer in the germ line (1) , leading to the production of transgenic animals, has had an enormous impact in biology. When the transgene results from random integration of a DNA fragment injected into a fertilized egg's pronucleus, its level of expression in the resulting transgenic animal varies and depends upon factors which cannot be controlled, such as the integration site and the transgene copy number. Usually, several transgenic mouse lines are created to ensure that the phenotype resulting from the presence of a transgene is reproducible and/or to select lines with high expression of the transgene. However, special difficulties arise when expression of the transgene results in sterility or is lethal before the age of reproduction. This situation requires the repeated production of new transgenic mice, each with a different transgene integration site and copy number, resulting in unwanted variations in experimental conditions. An additional complication may arise when high expression of a transgene is lethal, since transgenic founder embryos with weak expression of the transgene will be selected. Thus, observation of a partial phenotype may result in erroneous interpretations concerning the exact functions of the explored gene.
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To overcome these difficulties, expression of a potentially toxic transgene should be suppressed. This would allow the use of a single founder line stably transmitting the same transgene, provided reexpression of the transgene can be achieved under conditions controlled by the investigator. This could be obtained by a DNA recombination event mediated by the bacteriophage P1 cre gene, which encodes a recombinase, Cre, cleaving DNA at loxP sequences. The transgene may be introduced into a mouse in a "silenced" form by placing a loxP-flanked DNA sequence between its promoter and its coding sequence, thus preventing transcription. The transgene may be "reactivated" by mating mice of this line with mice of another transgenic line, expressing a cre transgene. Application of the Cre/loxP system to transgenic mice has already been reported, indicating efficient excision of the DNA located between the two loxP sequences in doubly transgenic mice, at least in tissues expressing the cre gene (2, 3 (7) , gift from B. Sauer] into the HindIII site located between the CAG promoter and lacZ. This 6.9-kb construct ( Fig. 1 ) was purified by electrophoresis and elution from NACS PREPAC (BRL) and used for microinjection. The plasmid pCAGGS-Cre was purified by NACS PREPAC, suspended in 1 mM Tris-HCl, pH 7.5/0.1 mM EDTA) at 5 ng/,ul, and used for microinjection. Transgenic mice were produced as described (8) . Proc. NatL Acad Sci USA 92 (1995) ,B-Galactosidase activity in the sample was measured by incubation with o-nitrophenyl 3-D-galactopyranoside (11) . RESULTS Experimental Design. The experimental design is outlined in Fig. 1 . The first step is the production of transgenic lines in which the coding region of the transgene of interest is preceded by a reporter/silencer transgene surrounded by lox sequences. The line(s) are then screened to determine which one(s) shows the strongest expression of the reporter/silencer. In this study, in order to easily monitor the expression of the two transgenes, we used the CAT and lacZ genes, and the injected construct was thus CAG promoter-1oxP-CAT-4oxP-lacZ (CAG-CAT-Z). In the next step, eggs are collected from mice of the transgenic line(s) and submitted to pronuclear injection of the plasmid pCAGGS-Cre in a circular form; this results in transient Cre expression and recombination at the loxP sequences. In embryos carrying the "recombined" transgene, 13-galactosidase activity is now detectable; the pCAGGSCre plasmids disappear rapidly by dilution during embryonic development.
The Cre Transient Expression System. To confirm that the CAG promoter works efficiently in fertilized eggs, we first injected circular pCAG-lacZ into fertilized eggs and stained them by X-Gal at the two-cell stage. All cells were stained very strongly (data not shown), showing that the CAG promoter has strong activity in eggs. We compared injection into the female or male pronucleus and found that at the two-cell stage the ,B-galactosidase staining was stronger with those injected in the female pronucleus, which may reflect the difference in the starting time of expression. The important point was that both pronuclear injections led to constant expression of the injected plasmid, which probably indicates that the CAG promoter is especially strong; indeed, other investigators, who injected lacZ plasmids placed under the control of different promoters into mouse eggs, have reported f3-galactosidase expression in only 50% (12) or less (13) of the injected eggs.
Production and Selection of Transgenic Lines. The CAG-CAT-Z construct was injected into fertilized eggs from B6D2F1 x B6D2F1 mice, and 12 transgenic founders were obtained. F1 mice were then obtained from each founder, and CAT activity present in the hearts of these F1 mice was determined. Three lines were found to display a high, comparable levels of CAT activity (data not shown). For further experiments, we chose one of these lines, CAG-CAT-Z 34, which carries about four copies of the transgene in head-to-tail arrangement (see Fig. 3c ), since it gave offspring more rapidly (Fig. 3) ; the stained embryo on the left had a recombined transgene and the unstained embryo on the right had no transgene (embryos with unrecombined transgene had an appearance similar to that of the embryo on the right).
than the others. Transmission of this transgene followed mendelian rules and never showed rearrangement or segregation.
Cre Expressed in Fertilized Eggs Recombines the loxContaining Transgene. Eggs from B6D2F1 females mated with CAG-CAT-Z 34 males were collected, and a solution (5 ng/,ul) of pCAGGS-Cre was injected into the male or female pronucleus. Injected eggs were then incubated and stained with X-Gal at the two-cell or four-cell stage. As shown in Fig. 2 To explore the second possibility, injected eggs were. transferred into foster mothers, and the resulting embryos were stained at 13 days of gestation; three embryos out of five were stained (Fig. 2) , with a ubiquitous and strong pattern of staining, suggesting that the recombination event had in fact occurred at the single-cell stage or eventually did occur in all cells; exploration of the placenta of these embryos by PCR showed that only the placentas of the stained embryo contained a lacZ gene, in the absence of the CAT gene (see below and Fig. 3 Fig. 3a , the Zl and Z2 primers were designed to explore whether the lacZ gene had been transmitted or not, the Z3 and AG2 primers to detect the recombination event, and the CAT2 and CAT3 primers to explore whether the CAT gene had been deleted completely. In the case of incomplete recombination and/or of mosaicism, the DNA samples should show PCRamplified DNA sequences with the use of CAT2/CAT3 primers and Z3/AG2 primers. Primers Crel and Cre2 were used to detect cre gene integration.
As shown in Table 2 , 18 of these 47 mice carried the transgene. Irrespective of the site of pronucleus injection, in all these 18 transgenic mice (which expressed lacZ; see below), DNA amplification using Z3 and AG2 primers gave a DNA segment of the expected size, whereas no amplified DNA segment was seen when the CAT2/CAT3 or Crel/Cre2 primer pairs were used (Fig. 3b) . Liver and kidney DNAs from some of these recombined-transgene-carrying mice gave the same pattern as tail DNAs (data not shown). This indicates that the expression of Cre in the injected transgenic eggs led to the excision of all CAT genes present in head-to-tail arrangement, that the cre gene was not integrated in the genome, and that the recombination event probably occurred very early in the embryos, since no mosaicism was detected.
Southern blot analysis of tail DNAs confirmed the existence of the expected recombination. As shown in Fig. 3a , recombination should reduce the four copies of the CAG-CAT-Z transgene array of transgenic line 34 to a recombined allele The eggs were obtained as described in Fig. 2 , and pCAGG-Cre was injected into the male or female pronucleus. After staining with X-Gal, stained eggs were counted. consisting of a single copy of the CAG promoter, the residual loxP site, and the lacZ gene. In agreement with this expectation, the recombined transgenic DNAs did not show the 4.4-kb band observed with the intact transgene (Fig. 3c Left) but instead showed the 3.1-kb band expected from the recombined DNA, with an intensity compatible with a single copy (Fig. 3c Right).
The lacZ Transgene in the Recombined Mice Shows a Tissue Distribution and Expression Level Comparable to Those of the Reporter/Silencer CAT Gene in the Parent Mice. Expression of the intact or recombined transgene was determined in the liver, kidney, spleen, heart, lung, and muscle (Table 3 ). In mice bearing the nonrecombined transgene, the CAT gene was expressed at very high levels in heart and muscle and only at C low levels in other tissues. In these mice, the transgene had no detectable f-galactosidase activity. In mice bearing a recombined transgene, 3-galactosidase activity was very high in muscle and heart; in the other tissues, it was not above the background level. This probably reflects the difference in sensitivity of the assays used, the CAT assay being more sensitive because of the lack of endogenous activity.
Transmission of the recombined transgene to progeny showed no evidence of instability.
DISCUSSION
These results establish a highly efficient method of genomic recombination whose product is subsequently expressed in all tissues and cells of the resulting animals. The injected eggs were transferred into foster mothers, and mice born as the result of this procedure were used when 3-4 weeks old. Tail DNAs were examined by PCR and the results with various primers (see Fig. 3 and Materials and Methods) are tabulated. Positive control for PCR detection of the cre sequence consisted of 1 pg of the cre plasmid and 1 ,ug of DNA from the tail of a nontransgenic mouse.
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